Aileron Therapeutics, Inc.
Aileron Therapeutics, Inc. (ALRN) Stock Overview
Explore Aileron Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
45.7M
P/E Ratio
-0.75
EPS (TTM)
$-2.88
ROE
-0.96%
ALRN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Aileron Therapeutics, Inc. (ALRN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.63.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.75 and a market capitalization of 45.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.